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A B S T R A C T
Objectives: The aim of the study was to molecularly characterize third-generation cephalosporin-
resistant Klebsiella pneumoniae isolated from bloodstream infections in Denmark in 2018 using whole-
genome sequencing (WGS) data, and to compare these isolates to the most common clones detected in
2006 and 2008.
Methods: Sixty-two extended-spectrum beta-lactamase (ESBL)/AmpC-producing K. pneumoniae isolates
from Danish blood cultures from 2018 were analysed using WGS to obtain multilocus sequence typing
(MLST), core genome MLST (cgMLST), resistance profile and phylogeny. These were compared to the most
common ESBL K. pneumoniae clones detected in 2006 and 2008.
Results: The most common ESBL clone was ST15 CTX-M-15, the DHA-1 enzyme was the most common in
AmpC isolates, and the OXA-48-like group was the most common carbapenemase. Thirty-nine different
sequencetypes(STs)were found,withthemostfrequentbeing ST14,ST15andST37,accounting for24%of the
isolates. The isolates were subdivided into 55 complex types (CTs) of which 49 were singletons, with the
most frequent being ST14-CT2080. Two of the CTX-M-15-producing isolates from 2018 belonged to the
ST15-CT105/CT3078 clone, which was first detected in 2006.
Conclusions: The ESBL/AmpC K. pneumoniae isolates detected in Danish blood cultures belonged to many
different types. No dominant clones were circulating in Danish hospitals, but the ST15-CT105/CT3078
CTX-M-15 K. pneumoniae clone was seen 13 years after its first detection.
© 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial
Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Journal of Global Antimicrobial Resistance
journal home page : www.e l sev ier .com/ loca te / jgar1. Introduction
Klebsiella pneumoniae is known to cause nosocomial infections,
such as urinary tract infections, abdominal infections and
bacteraemia. It can cause hospital outbreaks, probably because* Corresponding author at: Statens Serum Institut, 5 Artillerivej, 2300 Copenhagen S
E-mail address: ama@ssi.dk (A.M. Hammerum).
http://dx.doi.org/10.1016/j.jgar.2020.05.014
2213-7165/© 2020 The Authors. Published by Elsevier Ltd on behalf of International Societ
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).the hospital environment provides multiple niches beneficial for
bacterial survival and growth and K. pneumoniae is easily
transmitted by hands [1]. K. pneumoniae has recently been
characterized as a complex consisting of six phylogroups, the
K. pneumoniae sensu stricto, Klebsiella variicola, Klebsiella, Denmark.
y for Antimicrobial Chemotherapy. This is an open access article under the CC BY-NC-
S.K. Hansen et al. / Journal of Global Antimicrobial Resistance 22 (2020) 562–567 563quasivariicola, Klebsiella quasipneumoniae subsp. quasipneumoniae,
Klebsiella quasipneumoniae subsp. similipneumoniae and an un-
named phylogroup [2].
K. pneumoniae is inherently resistant towards aminopenicillins.
Furthermore, they can become resistant towards second- and
third-generation cephalosporins, most often caused by resistance
genes encoding AmpC or extended-spectrum beta-lactamase
(ESBL) production placed on plasmids often comprising additional
genes causing resistance towards fluoroquinolones and amino-
glycosides. In case of combined resistance, infections are more
difficult to treat and are associated with increased mortality and
morbidity and the ESBL-producing bacteria are therefore placed in
Priority 1: critical on the WHO priority pathogens list for Research
and Development of new antibiotics [3].
Before 2007, the prevalence of resistance towards second- and
third-generation cephalosporins in K. pneumoniae from blood-
stream infections was less than 5% in average in Denmark, but in
2007 a rise was registered [4]. Detection of a ST15 CTX-M-15-
producing K. pneumoniae clone started in 2006 in the Capital Region
(CR) and led to a regional collection and characterization of the
ESBL/AmpC-producing K. pneumoniae isolates. In 2008, a national
surveillance of ESBL/AmpC-producing K. pneumoniae from blood-
stream infections was completed and it revealed that the ST15 CTX-
M-15-producing clone was widespread in the CR of Denmark [5,6].
Furthermore, spread of an ST16 CTX-M-15-producing K. pneumo-
niae clone was detected in 2008 in the same region [7].
The aim of this study was to molecularly characterize ESBL/
AmpC- and carbapenemase-producing K. pneumoniae isolates
detected in blood cultures in Denmark in 2018 using whole-
genome sequencing (WGS) data and to compare the clonal
relationship of the findings from 2018 with the most common
CTX-M-15 K. pneumoniae clones detected in 2006 and 2008, to
observe if these clones were still present.
2. Materials and methods
2.1. Demographic data
Denmarkisdivided intofiveRegions (NUTs-level 2)— theCR, Region
Zealand (RZ), Central Region Denmark (CRD), Region of Southern
Denmark (RSD) and Region of Northern Denmark (RND), and the
population has for the last 10 years been around 5.5 million people.
2.2. Bacterial isolates
From January 2018 through December 2018, all Departments of
Clinical Microbiology (DCM) in Denmark voluntarily submitted
third-generation cephalosporin (cefpodoxime, ceftazidime, ceftri-
axone or cefotaxime)-resistant K. pneumoniae complex member
isolates from bloodstream infections to the National Reference
Laboratory at Statens Serum Institut (SSI), Denmark. Only one
isolate per patient was included in the study.
At SSI, ESBL and/or AmpC phenotypes were identified by a
combination disk method using Neo-SensitabsTM (Rosco, Taastrup,
Denmark).
The isolates from 2018 were compared with CTX-M-15-produc-
ing K. pneumoniae isolates belonging to the two most common
clones detected in the collections from 2006 and 2008, two ST15
CTX-M-15-producing K. pneumoniae isolates from 2006, six ST15
CTX-M-15-producing K. pneumoniae isolates from 2008 and one
ST16 CTX-M-15-producing K. pneumoniae isolate from 2008 [5–7].
2.3. WGS data analysis
The genomic DNA was extracted (DNeasy Blood and Tissue Kit,
Qiagen, Copenhagen, Denmark), with subsequent libraryconstruction (Nextera Kit, Illumina, Little Chesterford, UK) and
finally by WGS (MiSeq or Nextseq, Illumina) according to the
manufacturer’s instructions to obtain paired-end reads of 2  150
bp in length. Quality control was performed on the raw reads, using
the Bifrost pipeline at SSI (https://github.com/ssi-dk/bifrost) with
accepted average coverage >30.
The WGS data were either used as raw data or de novo
assembled using the assemblies generated using SKESA in Bifrost.
The raw reads of all isolates were assembled into draft genomes
using SKESA v. 2.2 in the Bifrost pipeline.
For identification of isolates belonging to the species K. variicola
and K. quasipneumoniae, the ribosomal multilocus sequence typing
(MLST) scheme (rMLST) based on 53 genes encoding ribosomal
proteins was used [8].
Resistance genes were identified using ResFinder version 2.1 [9]
(included in the Bifrost pipeline), using a threshold of 100% ID for
identifying genes encoding β-lactamases and carbapenemases and
98.00% ID for all other genes encoding transferable antimicrobial
resistance.
The draft genome data were also submitted through the
batch uploader for the Bacterial Analysis Platform (BAP) to the
Center for Genomic Epidemiology (https://cge.cbs.dtu.dk/ser-
vices/cge/) (CGE, DTU, Kgs. Lyngby, Denmark) [10]. Using the
pipeline-version 2.0, the CGE BAP automatically analysed the
data with the following tools: Kmerfinder 2.1, ContigAnalyzer
1.0, ResFinder 2.2 and MLST 1.6, resulting in species, ST and
resistance gene identification. The MLST (v. 1.6) web tool with
the Pasteur MLST scheme was used for identification of STs, as
part of the CGE BAP.
To further distinguish the isolates, the SeqSphere+ software
(Ridom, Münster, Germany) (using the K. pneumoniae sensu lato
cgMLST scheme [v. 1.0; 2358 loci]) was utilized to assign complex
types (CTs) based on the core genome with a cluster distance
threshold of 15 allele differences. The cgMLST scheme was able to
assign CTs for the species K. pneumoniae, K. variicola and
K. quasipneumoniae.
Isolates belonging to new STs were submitted to the Pasteur
Institute: https://bigsdb.pasteur.fr/klebsiella/klebsiella.html, and
isolates belonging to a new CT were submitted to Seqsphere + for
creation of a new CT.
3. Results
3.1. Demographic data for the ESBL/AmpC-producing K. pneumoniae
complex isolates
During 2018, 62 ESBL/AmpC-producing K. pneumoniae
blood culture isolates from 62 patients were collected at SSI,
with a regional contribution as follows: the CR (n = 27), RZ (n = 7),
RSD
(n = 10), CRD (n = 12) and the RND (n = 6) (Table 1).
Gender was distributed with a men/women ratio at 2.88, an
average age of 66 years and a median age of 68 years (men: average
age 67 years, median 69 years; women: average age 65 years,
median 65 years). No ESBL/AmpC-producing K. pneumoniae
isolates were detected from children (<18 years of age) with
bacteraemia.
3.2. Species identification and resistance genes
The 62 isolates were subdivided into 60 K. pneumoniae and two
K. quasipneumoniae.
Of the 62 isolates, five isolates were carbapenemase-producing,
59 isolates were ESBL-producing and five isolates were AmpC-
positive.
Table 1
Characterization of ESBL/AmpC-producing Klebsiella pneumoniae complex isolates from bloodstream infections 2018, Denmark.
Phenotype MLST
(ST)
cgMLST
(CT)
Genotype No. of isolates Region
(NUTs-2 level)
Carbapenemases Extended
spectrum
beta-
lactamases
AmpC
beta-
lactamases
Fluoroquinolone
resistance genes
Aminoglycoside
resistance genes
Aminoglycoside/
fluoroquinolone
resistance genes
CPO/ESBL ST101 CT2089 OXA-48 CTX-M-15 oqxA, oqxB aac(3)-IIa, aac(60)-Ib aac(60)-Ib-cr 2 CR
ST147a CT1789 OXA-48 CTX-M-15 DHA-1 oqxA, oqxB, qnrB4 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
ST231 CT2102 OXA-232 CTX-M-15 oqxA, qnrS1 aadA2 aac(60)-Ib-cr 1 CRD
ST3457 CT2157 OXA-48 CTX-M-3 oqxA, oqxB, qnrS1 aph(6)-Id 1 RZ
ESBL ST14 CT2080 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 3 CR, CRD
CT2231 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 RZ
CT2252 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
CT2257 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib, aph(30)-Ia 1 CR
CT3077 CTX-M-15 oqxA, oqxB aph(6)-Id, aph(300)-Ib 1 CRD
ST15a CT105 CTX-M-15 oqxA, oqxB aph(6)-Id, aph(300)-Ib 1 CR
CT2128 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib, aac(3)-IIa aac(60)-Ib-cr 1 RND
CT3076 CTX-M-15 oqxA aac(3)-IId, aadA2, aph(30)-Ia aac(60)-Ib-cr 1 CR
CT3078 CTX-M-15 oqxA, oqxB aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
ST20 CT2273 CTX-M-154 oqxA, oqxB aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 RND
ST25 CT2232 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 RSD
ST37 CT2710 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib, aac(3)-IIb aac(60)-Ib-cr 1 CRD
CT2793 CTX-M-15 oqxA, oqxB aph(6)-Id, aph(300)-Ib, aac(3)-IIb aac(60)-Ib-cr 1 RSD
CT3088 CTX-M-14 oqxA, oqxB, qnrS1 aac(3)-IId 1 RND
CT3093 CTX-M-14 oqxA, oqxB 1 CR
ST45 CT2195 CTX-M-15 oqxA, oqxB aph(6)-Id, aph(300)-Ib, aac(3)-IIa aac(60)-Ib-cr 1 CRD
CT2229 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib, aac(3)-IIa aac(60)-Ib-cr 1 RSD
ST46 CT3080 SHV-27 oqxA, oqxB aadA2 1 CRD
ST48 CT829 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 CR
ST70a CT2127 CTX-M-15 oqxA, oqxB, qnrB1b aac(3)-IId, aac(60)-Ibb, aph(300)-Ibb, aph(6)-Ibb aac(60)-Ib-cr 2 CR, RND
ST152 CT3082 CTX-M-15 oqxA, oqxB, qnrB6 aac(3)-IIa, aadA16, aph(30)-Ia, aph(300)-Ib aac(60)-Ib-cr 1 RZ
ST219 CT3091 CTX-M-15 oqxA, oqxB, qnrS1 aph(6)-Id, aadA2, aph(30)-Ia, aph(300)-Ib 1 CR
ST231 CT3079 CTX-M-15 oqxA, oqxB 1 RSD
ST268 CT3081 CTX-M-15 oqxA, oqxB aac(3)-IIa, aph(30)-Ia, aadA5 aac(60)-Ib-cr 1 RSD
ST307 CT932 CTX-M-14 oqxA, oqxB, qnrB1 aac(60)-Ib-cr 1 CRD
CT2110 CTX-M-15 DHA-1 oqxA, oqxB, qnrB1, qnrB4 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CRD
CT3075 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
ST359 CT2251 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IIa, aph(6)-Id aac(60)-Ib-cr 1 CR
ST414c CT3072 CTX-M-15 oqxA, oqxB aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
ST416 CT3089 CTX-M-3 oqxA, oqxB 1 CR
ST474a CT1937 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 RSD
ST491 CT2276 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 RZ
ST711 CT2198 CTX-M-15 oqxA, oqxB, qnrB1 1 RSD
ST846 CT2256 CTX-M-15 oqxA, oqxB, qnrB1 aac(60)-Ib-cr 1 RZ
ST915 CT3090 CTX-M-15 oqxA, oqxB aac(3)-IId 2 CR
ST985 CT2196 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 2 CRD
ST999 CT3073 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 CR
ST1128 CT2193 CTX-M-55 oqxA, oqxB, qnrS1 aph(30)-IIa 2 RZ
ST1564 CT2197 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
CT3086 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 CR
CT3092 CTX-M-15 oqxA, oqxB, qnrB1 aph(6)-Id, aph(300)-Ib 1 CR
ST1662 CT2954 CTX-M-15 oqxA, oqxB, qnrS1 aph(6)-Id, aph(300)-Ib, aph(30)-Ia, aadA2 1 RSD
ST2441 CT2126 CTX-M-15 oqxA, oqxB aac(3)-IId, aadA2 1 RND
ST2663c CT2205 SHV-12 oqxA, oqxB, qnrB1 1 CRD
ST2724 CT3071 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IIa, aph(6)-Id, aph(300)-Ib aac(60)-Ib-cr 1 CR
ST3157 CT3087 CTX-M-55 oqxA, oqxB 1 CR
ST3233 CT1936 CTX-M-15 oqxA, oqxB, qnrB1 aac(3)-IId, aph(6)-Id, aph(300)-Ib 1 RSD
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S.K. Hansen et al. / Journal of Global Antimicrobial Resistance 22 (2020) 562–567 565All five carbapenemase-positive isolates belonged to the
OXA-48-group: four OXA-48 and one OXA-232.
The most prevalent ESBL genotype was a blaCTX-M-15 detected in
48 of the 62 isolates, while all the five AmpC-producing isolates
harboured the blaDHA-1 gene (Table 1).
Eighty-five percent of the isolates were found containing one or
several plasmid-mediated aminoglycoside resistance genes. Fur-
thermore, all isolates, but one, harboured one or several genes
encoding fluoroquinolone resistance with the aminoglycoside
acetyltransferase variant gene aac(60)-Ib-cr being present in 28 of
the 62 isolates (Table 1).
3.3. Phylogenetic analysis
The 62 isolates belonged to 39 STs, with the most frequent being
ST14, ST15 and ST37, accounting for 24% of the isolates. Typing by
cgMLST revealed 55 different CTs, with 49 singletons and six CTs
consisting of more than one isolate. The most common CT with
three isolates was CT2080 from the ST14 cluster, while the
CTs–CT2089, CT2127, CT2193, CT2196 and CT3090 each consisted
of two isolates (Table 1).
3.4. Comparison of the ESBL-producing K. pneumoniae isolates from
2018, 2008 and 2006
The two ST15 CTX-M-15-producing K. pneumoniae isolates from
2006 and the six ST15 CTX-M-15-producing K. pneumoniae isolates
from 2008 belonged to CT105. A single ST15-CT105 CTX-M-15-
producing isolate was also detected in 2018. Furthermore, one of
the CTX-M-15-producing isolates from 2018 belonged to ST15-
CT3078, which was a subtype of ST15-CT105 (11 allele difference).
The ST16 CTX-M-15-producing K. pneumoniae isolates from 2008
belonged to CT3476. None of the ESBL-producing K. pneumoniae
isolates from 2018 belonged to ST16 or to CT3476.
4. Discussion
Antimicrobial resistance in K. pneumoniae has for several
years been of great concern worldwide, because of its ability to
obtain plasmids harbouring resistance towards third-generation
cephalosporins, aminoglycosides, fluoroquinolones and carbape-
nems.
From 2006 to 2014, an increase in the prevalence of invasive
K. pneumoniae isolates resistant to third-generation cephalospor-
ins was observed in all of Europe, but thereafter, no common trend
has been registered. Regarding invasive carbapenemase-producing
K. pneumoniae, a significant increase in prevalence has been
observed since 2015 [11].
In our investigation, we found that the most frequent resistance
genes in the Danish ESBL K. pneumoniae isolates have not changed
during the last 11 years and that the blaCTX-M-15 gene remains the
most frequent ESBL gene [7]. In our study, four carbapenemase-
producing K. pneumoniae harboured the OXA-48 enzyme, which is
the most frequent enzyme identified in the OXA-48-like carbape-
nemase group. One carbapenemase-producing K. pneumoniae
contained the OXA-232 enzyme, which also belongs to the OXA-
48-like carbapenemase group and is the third most common OXA-
48-like carbapenemase [12].
The aac(3)-II gene and the aac(60)-Ib-cr gene were the most
prevalent aminoglycoside and fluoroquinolone resistance genes in
2018, which were similar to 2008 [7].
Very few isolates in the 2018 collection belonged to the same
STs and further differentiation with cgMLST revealed more than 50
different CTs, with ST14-CT2080 being the most frequent. Isolates
belonging to the same CTs were obtained from the same regions in
Denmark.
566 S.K. Hansen et al. / Journal of Global Antimicrobial Resistance 22 (2020) 562–567Two OXA-48-producing K. pneumoniae isolates belonged to
ST101 and one to ST147. Both types have been reported as global
high-risk clones and are reported worldwide [12]. Furthermore,
one isolate of ST231 OXA-232 was found. This clone was identified
for the first time in 2011 in France, and has later been reported from
USA and India and as an epidemic clone in South-East Asia [13,14].
The ST15 CTX-M-15-producing K. pneumoniae has been isolated
from humans in several countries in both Europe and Asia [15]. It
has also been described from companion animals and horses [16].
In Denmark, spread of a ST15 CTX-M-15 K. pneumoniae clone
was first detected in 2006 [5]. In 2008, this clone was detected
from patients with bloodstream infections hospitalized in the CR of
Denmark [7]. In our study, six ST15 CTX-M-15-producing isolates
belonging to the major ST15 clone in 2006 and two ST15 CTX-M-15
isolates from 2008 were typed by cgMLST and were all found to
belong to CT105. One ST15-CT105 CTX-M-15-producing isolate and
one ST15-CT3078 isolate, which was a subtype of ST15-CT105
(11 allele difference), were detected in the 2018 collection, both
from patients hospitalized in the CR. This could indicate a spread of
this clone during the 13-year period in the CR. The origin of the
ST15-CT105 CTM-X-15 clone was unknown, but from the cgMLST
database (www.cgMLST.org) information was available for a
ST15-CT105 CTM-X-15 K. pneumoniae isolate from 2007. This
isolate was found in an American wounded military person
(GenBank accession no. GCA_000788005.1).
Generally, Denmark and other Nordic countries have a low
prevalence of resistance towards third-generation cephalosporins,
carbapenems as well as combined resistance to third-generation
cephalosporins, fluoroquinolones and aminoglycosides compared
to the rest of Europe [11]. Historically, the proportion of invasive
K. pneumoniae with phenotypic resistance towards third-genera-
tion cephalosporins in Denmark has imitated the increasing trend
inthe restofEuropeuntil2009, followedbyacontinuousdecrease.At
the sametime,thenumberofcarbapenemase-producingisolateshas
continuously been low. Since 2014, DANMAP has registered
combined resistance towards third-generation cephalosporins,
ciprofloxacin and gentamicin in the Danish invasive K. pneumoniae
isolates, and reported an annual percentage of around 2% [4,17].
The decrease in the third-generation resistance and resistance
towards gentamicin in the Danish K. pneumoniae isolates may be
due to several things, of which the main reason probably is a
restrictive use of antibiotics. The relation between selection of
ESBL-producing species and the total antibiotic consumption, as
well as the specific use of second- and third-generation
cephalosporins and fluoroquinolones, led to an implementation
of antibiotic stewardship. The stewardship was implemented in
2007 in hospitals with nosocomial ESBL/AmpC K. pneumoniae
outbreaks [7]. Antibiotic stewardship involved restriction of
cephalosporins, fluoroquinolones and carbapenems and a change
of empiric treatment from cefuroxime to piperacillin–tazobactam
[4,18]. In 2012, The Danish Health and Medicines Authority
introduced an antibiotic guideline that included restrictions on the
prescription of cephalosporins, fluoroquinolones and carbape-
nems in primary healthcare and in hospitals. Furthermore, in 2017,
the Danish Ministry of Health defined a national action plan and
published national goals for the reduced consumption of
antimicrobial agents in humans [19,20].
In our study, we only investigated isolates from bloodstream
infections, which is a limitation. A more thorough investigation of
the clonal dissemination would have been possible if isolates from
faecal and urine isolates also had been included.
In conclusion, ESBL/AmpC-producing K. pneumoniae bacter-
aemia isolates from Denmark collected in 2018 belonged to
many different types and no clonal dissemination was detected in
the blood samples from the Danish hospitals. However, a
ST15-CT105/3078 CTX-M-15-producing K. pneumoniae clonefrom 2006 was detected. The numbers of ESBL/AmpC-producing
K. pneumoniae were at a low and stable level, which may
indicate that the different initiatives taken during the 2000s
were effective.
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